山东中医杂志2026，Vol.45Issue(3)：273-276,4.DOI:10.16295/j.cnki.0257-358x.2026.03.009
从络病理论辨治糖尿病心肌病心肌纤维化
Syndrome Differentiation and Treatment of Myocardial Fibrosis in Diabetic Cardiomyopathy Based on the Collateral Disease Theory
摘要
Abstract
Diabetic cardiomyopathy with myocardial fibrosis is located in the heart collaterals and can be classified under the category of collateral disorders.The theory of collateral disorders plays a significant guiding role in its diagnosis and treatment.The formation process of this disease is relatively slow,with a long course of illness.The main pathological evolution process is characterized by deficiency of both qi and yin,and obstruction of the heart collaterals,which then progresses from collaterals to vessels(heart),conforming to the basic rule of"chronic diseases entering collaterals"in traditional Chinese medicine.The treatment should focus on tonifying qi and nourishing yin,resolving stasis and unblocking collaterals.Based on this,"Tangxin Kang"Formula(糖心康)is prescribed,with Huangqi(Astragali Radix)and Shanyao(Dioscoreae Rhizoma)as the sovereign medicinals,Gegen(Puerariae Lobatae Radix)and Danshen(Salvia Miltiorrhizae Radix et Rhizoma)as the ministerial medicinals,and Guijianyu(Ramulus Alatus Euonymi),Shuizhi(Hirudo)and Quanxie(Scorpio)as the adjuvant medicinals.This formula has achieved good therapeutic effects in clinical applications.A test case is attached.关键词
糖尿病心肌病/心肌纤维化/络病理论/益气养阴/化瘀通络/糖心康Key words
diabetic cardiomyopathy/myocardial fibrosis/collateral disease theory/tonify qi and nourish yin/resolving stasis and unblocking collaterals/Tangxin Kang Formula分类
医药卫生引用本文复制引用
宋志聪,李捷,桑素珍,张夕海,吕泰龙,部帅..从络病理论辨治糖尿病心肌病心肌纤维化[J].山东中医杂志,2026,45(3):273-276,4.基金项目
国家重点研发计划(编号:2023YFC3606203) （编号:2023YFC3606203）
山东省泰山学者工程专项经费项目(编号:ts201712097) （编号:ts201712097）
